Syndrome  >>  INCB47986  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
INCB47986 / Incyte
NCT02093429: Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)

Terminated
1/2
6
US
INCB047986
Incyte Corporation
MDS (Myelodysplastic Syndrome)
09/14
09/14

Download Options